Page 36 - CASA Bulletin of Anesthiology 2021, Vol 8, No. 6 (1)

CASA Bulletin of Anesthesiology

Reference

1. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm
Rep;65(1):1-49.
2. Maine Legislature. PUBLIC Law, Chapter 488: An Act to Prevent Opiate Abuse By Strengthening the Controlled Substances Prescription
Monitoring Program. Sec. 13. 32 MRSA §2210 1.A. (7/29/2016)
3. Nevada Legislature. Assembly Bill 474: Committee on Health and Human Services. Section 52. 2. b. (3/27/2017)
4. Rhode Island General Assembly. Chapter 199. Section 21-28-3.20.c. (6/28/2016)
5. McCoy, Terrence. “’Unintended Consequences’: Inside the fallout of America’s crackdown on opioids.” Washington Post. (5/31/2018)
6. Rubin R. "Limits on Opioid Prescribing Leave Patients with Chronic Pain Vulnerable," JAMA 321;21:2059-2062.
7. Kamdar NV, Hoftman N, Rahman S, Cannesson M. Opioid-Free Analgesia in the Era of Enhanced Recovery After Surgery and the Surgical
Home: Implications for Postoperative Outcomes and Population Health. Anesth Analg. 2017 Oct;125(4):1089-1091.
8. Dowell D, Haegerich T, Chou R. No Shortcuts to Safer Opioid Prescribing. N Engl J Med. 2019 Jun 13;380(24):2285-2287. Epub 2019 Apr
24.
9. Health Professionals for Patients in Pain (HP3). Professionals Call on the CDC to Address Misapplication of its Guideline on Opioids for
Chronic Pain through Public Clarification and Impact Evaluation. (3/6/2019)
https://docs.google.com/document/d/1RzQDSppUKhjiAsEmhW2WbTXlP5V8vJ4M_vBPQLKhK_8/edit. Accessed on 12/12/21
10. Carlson RW, Hudis CA, Liggett M. Letter to Deborah Dowell, MD, MPH. 2/13/2019. https://www.asco.org/sites/new-
www.asco.org/files/content-files/advocacy-and-policy/documents/2019-NCCN-ASCO-ASH-Letter-CDC.pdf. Accessed 12/12/2021
11. Tseng KS. Considerations in 2017-2018 for the Use of Opioids in Non-terminal Pain. Curr Anesthesiol Rep 2018 Dec;8(4):342-347.
12. Santella TM, Triggle DJ. Opium. Facts On File, Incorporated; 2009. p. 8.
13. Morimoto S, Suemori K, Moriwaki J, Taura F, Tanaka H, Aso M, et al. Morphine Metabolism in the Opium Poppy and Its Possible
Physiological Function. J Biol Chem. 2001; 276 (41): 38179–38184.
14. Judson HF. Heroin Addiction. Vintage Books; 1974. p. 54.
15. United Nations Office on Drugs and Crime. “The 1912 Hague International Opium Convention.” 1/23/2019.
https://www.unodc.org/unodc/en/frontpage/the-1912-hague-international-opium-convention.html. Accessed 12/12/2021
16. Congress of the United States. “Harrison Narcotics Tax Act.” Ch. 1, 38 Stat. 785. (12/17/1914)
17. Sneader W. Drug discovery: a history. Chichester: Wiley; 2005.
18. U.S. Code § 812. Schedules of controlled substances.
19. Porter J, Jick H. Addiction rare in patients treated with narcotics. N Engl J Med. 1980 Jan 10;302(2):123.
20. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain 1986 May;25(2):171-86.
21. Melzack R. The Tragedy of Needless Pain. Sci Am. 1990 Feb;262(2):27-33.
22. Max MB. Improving outcomes of analgesic treatment: is education enough? Ann Intern Med. 1990 Dec 1;113(11):885-9.
23. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. JAMA
1995 Dec 20;274(23):1874-80.
24. Baker DW. History of the Joint Commission’s Pain Standards: Lessons for Today’s Prescription Opioid Epidemic. JAMA. 2017;
317(11)1117-1118.
25. Congress of the United States. H.R. 3244. Title 6, Sec. 1603. (10/31/2000)
26. The Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD Clinical Practical Guidelines for the management of opioid
therapy for chronic pain. 2003.
27. Baker DW. History of the Joint Commission’s Pain Standards: Lessons for Today’s Prescription Opioid Epidemic. JAMA. 2017;
317(11)1117-1118.
28. CDC/NCHS, National Vital Statistics System, Mortality. CDC WONDER, Atlanta, GA: US Department of Health and Human Services,
CDC.
29. American Pain Society. Guideline for the use of chronic opioid therapy in chronic noncancer pain: evidence review. American Academy of
Pain Medicine Opioids Guidelines Panel; Chicago, IL: American Pain Society, 2009.
30. Chou R, Deyo R, Devine B, Hansen R, Sullivan S, Jarvik JG, Blazina I, Dana T, Bougatsos C, Turner J. The Effectiveness and Risks of
Long-Term Opioid Treatment of Chronic Pain. Evidence Report/Technology Assessment No. 218. (Prepared by the Pacific Northwest
Evidence-based Practice Center under Contract No. 290-2012-00014-I.) AHRQ Publication No. 14-E005-EF. Rockville, MD: Agency for
Healthcare Research and Quality; September 2014.
31. Allan L, Richarz U, Simpson K, Slappendel R. Transdermal fentanyl versus sustained release oral morphine in strong-opioid naive patients
with chronic low back pain. Spine (Phila Pa 1976) 2005 Nov 15;30(22):2484-90.
32. Krebs EE, Gravely A, Nugent S, Jensen AC, DeRonne B, Goldsmith ES, et al. Effect of Opioid vs Nonopioid Medications on Pain-Related
Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial. JAMA 2018 Mar
6;319(9):872-82.
33. Agnoli A, Xing G, Tancredi DJ, Magnan E, Jerant A, Fenton JJ. Association of Dose Tapering With Overdose or Mental Health Crisis
Among Patients Prescribed Long-term Opioids. JAMA. 2021 Aug 3;326(5):411-419.
34. Kharasch ED, Clark JD; Opioid-free Anesthesia: Time to Regain Our Balance. Anesthesiology 2021; 134:509–514.
35. U.S. Department of Health and Human Services. Pain Management Best Practices Inter-Agency Task Force Report: Updates, Gaps,
Inconsistencies, and Recommendations. May 2019. https://www.hhs.gov/sites/default/files/pmtf-final-report-2019-05-23.pdf. Accessed
12/15/2021
36. American Medical Association. ”AMA backs update to CDC opioid prescribing guidelines.” (7/22/2021). https://www.ama-assn.org/press-
center/press-releases/ama-backs-update-cdc-opioid-prescribing-guidelines. Accessed 12/14/21

P a g e 35 | 69